Mangoceuticals (MGRX) Cash from Operations Growth (3y) (2026)
Mangoceuticals (MGRX) Cash from Operations Growth (3y) (2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.28 Bn | 24.97 Bn | 662.02 Mn | 30.60% |
| 2 | BrightSpring Health Services | 14.62 Bn | 13.72 Bn | 482.22 Mn | 45.52% |
| 3 | Healthequity | 8.35 Bn | 8.08 Bn | 256.31 Mn | 45.69% |
| 4 | Hinge Health | 5.98 Bn | 5.67 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn | 102.73% |
| 6 | MiniMed | 4.50 Bn | 4.20 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.47 Bn | 4.41 Bn | 216.84 Mn | - |
| 8 | Doximity | 3.96 Bn | 3.21 Bn | 125.97 Mn | 32.92% |
| 9 | Privia Health | 3.13 Bn | 2.71 Bn | - | -54.61% |
| 10 | Mangoceuticals | 8.95 Mn | 8.76 Mn | 29,001.00 | 10.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.16% |